QIDILA Whitening Skin Lightening Cream .05 g/100mL
BUTYLENE GLYCOL,BUTYROSPERMUM PARKII (SHEA BUTTER),KYOUNIN YU,TOCOPHEROL,ASCORBIC ACID,NIACINAMIDE · CREAM · Beijing JUNGE Technology Co., Ltd.
QIDILA Whitening Skin Lightening Cream is a cream containing butylene glycol,butyrospermum parkii (shea butter),kyounin yu,tocopherol,ascorbic acid,niacinamide at .05 g/100mL, taken extracorporeal. Manufactured by Beijing JUNGE Technology Co., Ltd..
Key Facts
- Brand Name
- QIDILA Whitening Skin Lightening Cream
- Generic Name
- BUTYLENE GLYCOL,BUTYROSPERMUM PARKII (SHEA BUTTER),KYOUNIN YU,TOCOPHEROL,ASCORBIC ACID,NIACINAMIDE
- NDC Code (Product)
85212-0006- Manufacturer
- Beijing JUNGE Technology Co., Ltd.
- Strength
- .05 g/100mL
- Dosage Form
- CREAM
- Route
- EXTRACORPOREAL
- Marketing Status
- Application #
- 505G(a)(3)
- Drug Class
- Vitamin C [EPC]
- Marketing Start
- 01/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is QIDILA Whitening Skin Lightening Cream used for?
QIDILA Whitening Skin Lightening Cream contains BUTYLENE GLYCOL,BUTYROSPERMUM PARKII (SHEA BUTTER),KYOUNIN YU,TOCOPHEROL,ASCORBIC ACID,NIACINAMIDE. It is a cream taken extracorporeal. Consult your doctor for specific uses.
Is QIDILA Whitening Skin Lightening Cream a controlled substance?
QIDILA Whitening Skin Lightening Cream is not classified as a controlled substance by the DEA.
What is the generic name for QIDILA Whitening Skin Lightening Cream?
The generic name for QIDILA Whitening Skin Lightening Cream is BUTYLENE GLYCOL,BUTYROSPERMUM PARKII (SHEA BUTTER),KYOUNIN YU,TOCOPHEROL,ASCORBIC ACID,NIACINAMIDE. There are no other listed brand versions of BUTYLENE GLYCOL,BUTYROSPERMUM PARKII (SHEA BUTTER),KYOUNIN YU,TOCOPHEROL,ASCORBIC ACID,NIACINAMIDE.
What is the NDC code for QIDILA Whitening Skin Lightening Cream .05 g/100mL?
The NDC (National Drug Code) for QIDILA Whitening Skin Lightening Cream .05 g/100mL is 85212-0006, listed by Beijing JUNGE Technology Co., Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)